XML 173 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Income and Social Contribution Taxes
12 Months Ended
Dec. 31, 2019
Text block [abstract]  
Income and Social Contribution Taxes
9. Income and Social Contribution Taxes
a. Deferred Income (IRPJ) and Social Contribution Taxes (CSLL)
The Company and its subsidiaries recognize deferred tax assets and liabilities, which are not subject to the statute of limitations, resulting from tax loss carryforwards, temporary differences, negative tax bases and revaluation of PP&E, among others. Deferred tax assets are sustained by the continued profitability of their operations. Deferred IRPJ and CSLL are recognized under the following main categories:
 
   
12/31/2019
   
12/31/2018
 
Assets—Deferred income and social contribution taxes on:
    
Provision for impairment of assets
   72,377    116,191 
Provisions for tax, civil, and labor risks
   150,085    154,516 
Provision for post-employment benefits
   92,199    85,575 
Provision for differences between cash and accrual basis
(*)
   224,065    147,376 
Goodwill
   8,161    12,258 
Business combination – tax basis vs. accounting basis of goodwill
   75,745    75,838 
Provision for asset retirement obligation
   14,762    15,801 
Provision for suppliers
   35,214    38,339 
Provision for profit sharing and bonus
   44,818    49,621 
Leases payable
   19,003    —   
Change in fair value of subscription warrants
   16,338    13,700 
Other provisions
   45,316    42,694 
Tax losses and negative basis for social contribution carryforwards (d)
   278,140    208,036 
  
 
 
   
 
 
 
Total
   1,076,223    959,945 
  
 
 
   
 
 
 
Offset the liability balance of deferred IRPJ and CSLL
   (422,529   (445,758
  
 
 
   
 
 
 
Net balance of deferred taxes assets
   653,694    514,187 
  
 
 
   
 
 
 
Liabilities—Deferred income and social contribution taxes on:
    
Revaluation of PP&E
   1,866    1,981 
Lease payable
   2,356    2,858 
Provision for differences between cash and accrual basis
(*)
   257,718    138,332 
Provision for goodwill
   39,186    187,845 
Business combination – fair value of assets
   114,125    117,352 
Other provisions
   14,809    6,687 
  
 
 
   
 
 
 
Total
   430,060    455,055 
  
 
 
   
 
 
 
Offset the asset balances of deferred IRPJ and CSLL
   (422,529   (445,758
  
 
 
   
 
 
 
Net balance of deferred taxes liabilities
   7,531    9,297 
  
 
 
   
 
 
 
 
(*)
 
Refers mainly to the income tax on the exchange variation of the hedging instruments.
 
Changes in the net balance of deferred IRPJ and CSLL are as follows:
 
   
2019
   
2018
   
2017
 
Initial balance
   504,890    530,419    451,973 
Deferred IRPJ and CSLL recognized in income of the year
   97,465    (162,417   109,204 
Deferred IRPJ and CSLL recognized in other comprehensive income
   40,497    133,124    13,389 
Deferred IRPJ and CSLL recognized in business combination 
       1,054    (45,728
Others
   3,311    2,710    1,581 
  
 
 
   
 
 
   
 
 
 
Final balance
   646,163    504,890    530,419 
  
 
 
   
 
 
   
 
 
 
The estimated recovery of deferred tax assets relating to IRPJ and CSLL is stated as follows:
 
Up to 1 Year
   178,127 
From 1 to 2 Years
   54,814 
From 2 to 3 Years
   141,105 
From 3 to 5 Years
   136,029 
From 5 to 7 Years
   353,806 
From 7 to 10 Years
   212,342 
  
 
 
 
Total of deferred tax assets relating to IRPJ and CSLL
   1,076,223 
  
 
 
 
In order to evaluate the realization of deferred tax assets, the taxable income projections from business plans of each segment of the Company, approved by Company’s Board of Directors, which indicates trends and perspectives, demand effects, competition and other economic factors that represent the management’s best estimate about the economic conditions existing during the period of realization of the deferred tax asset were taken into account.
The main key assumptions used to calculate the realization of deferred tax assets are: growth in Gross Domestic Product (“GDP”), exchange rate, basic interest rate (SELIC) and DI, inflation rate, commodity price index, among others. The balance of R$ 1,076,223 was supported by the technical study on taxable income projections for the realization of deferred tax assets, reviewed by the Fiscal Council and by the Audit and Risks Committee and approved by Company’s Board of Directors.
 
b. Reconciliation of Income and Social Contribution Taxes
IRPJ and CSLL are reconciled to the statutory tax rates as follows:
 
   
2019
   
2018
   
2017
 
Income before taxes and share of profit (loss) of subsidiaries, joint ventures, and associates
   793,698    1,785,818    2,318,446 
Statutory tax rates - %
   34    34    34 
  
 
 
   
 
 
   
 
 
 
Income and social contribution taxes at the statutory tax rates
   (269,857   (607,178   (788,272
  
 
 
   
 
 
   
 
 
 
Adjustments to the statutory income and social
contribution taxes:
      
Nondeductible expenses (i)
   (68,795   (82,784   (105,017
Nontaxable revenues (ii)
   28,235    32,523    19,084 
Adjustment to estimated income (iii)
   10,511    9,706    10,844 
Interest on equity (iv)
   0    (538   (550
Unrecorded deferred Income and Social
Contribution Taxes Carryforwards deferred (v)
   (146,820   (95,480   —   
Other adjustments
   24,873    (2,634   2,059 
  
 
 
   
 
 
   
 
 
 
Income and social contribution taxes before tax incentives
   (421,853   (746,385   (861,852
  
 
 
   
 
 
   
 
 
 
Tax incentives—SUDENE
   43,244    107,666    48,598 
  
 
 
   
 
 
   
 
 
 
Income and social contribution taxes in the income statement
   (378,609   (638,719   (813,254
  
 
 
   
 
 
   
 
 
 
Current
   (476,074   (476,302   (922,458
Deferred
   97,465    (162,417   109,204 
Effective IRPJ and CSLL rates - %
   47.7    35.8    35.1 
 
(i)
Consist of certain expenses that cannot be deducted for tax purposes under applicable tax legislation, such as expenses with fines, donations, gifts, losses of assets, negative effects of foreign subsidiaries and certain provisions;
(ii)
Consist of certain gains and income that are not taxable under applicable tax legislation, such as the reimbursement of taxes and the reversal of certain provisions;
(iii)
Brazilian tax law allows for an alternative method of taxation for companies that generated gross revenues of up to R$ 78 million in their previous fiscal year. Certain subsidiaries of the Company adopted this alternative form of taxation, whereby income and social contribution taxes are calculated on a basis equal to 32% of operating revenues, as opposed to being calculated based on the effective taxable income of these subsidiaries. The adjustment to estimated income represents the difference between the taxation under this alternative method and the income and social contribution taxes that would have been paid based on the effective statutory rate applied to the taxable income of these subsidiaries;
(iv)
Interest on equity is an option foreseen in Brazilian corporate law to distribute profits to shareholders, calculated based on the long-term interest rate (“TJLP”), which does not affect the income statement, but is deductible for purposes of IRPJ and CSLL, being taxable to the beneficiary and deductible to the entity that pays;
(v)
See Note 9.d.
c. Tax Incentives—SUDENE
The following subsidiaries are entitled to federal tax benefits providing for IRPJ reduction under the program for development of northeastern Brazil operated by the Superintendence for the Development of the Northeast (“SUDENE”), as shown below:
 
Subsidiary
  
Units
  
Incentive -
%
  
Expiration
Bahiana Distribuidora de Gás Ltda.
  Mataripe base  75  2024
  Caucaia base  75  2025
  Juazeiro base  75  2026
  Aracaju base 
(1)
  75  2027
  Suape base
(2)
  75  2027
Terminal Químico de Aratu S.A. – Tequimar
  Suape terminal  75  2020
  Aratu terminal  75  2022
  Itaqui terminal  75  2025
Oleoquímica Indústria e Comércio de Produtos Químicos Ltda.
  Camaçari plant  75  2021
Oxiteno S.A. Indústria e Comércio
(3)
  Camaçari plant  75  2026
Empresa Carioca de Produtos Químicos S.A.
  Camaçari plant  75  2026
 
(1)
The subsidiary Bahiana Distribuidora de Gás Ltda. (“Bahiana”), obtained 75% income tax reduction incentive recognized by SUDENE, through an appraisal report on October 22, 2018, until 2027, due to the modernization for its Aracaju plant – Sergipe. Due to the tacit approval by the RFB the constitutive benefit appraisal report the subsidiary recognized income tax reduction retroactive effect in January 2018 in the amount of R$ 1,067.
(2)
The subsidiary Bahiana had the 75% income tax reduction incentive recognized by SUDENE, through an appraisal report on January 14, 2019, until 2027, due to the modernization for its Suape plant – Pernambuco. The constitutive benefit appraisal report was approved in May 2019 by the RFB.
(3)
 
The request to transfer the right to reduce the IRPJ to Oxiteno S.A. will be submitted to SUDENE due to the incorporation of the subsidiary Oxiteno Nordeste.
d. Income and Social Contribution Taxes Carryforwards
In December 31, 2019, the Company and certain subsidiaries had tax loss carryforwards related to income tax (IRPJ) of R$ 1,268,964 (R$ 873,718 as of December 31, 2018) and negative basis of CSLL of R$ 1,270,714 (R$ 876,315 as of December 31, 2018), whose compensations are limited to 30% of taxable income in a given tax year, which do not expire.
In addition, certain offshore subsidiaries had tax loss carryforwards of R$ 878,470 (R$ 620,906 as of December 31, 2018).
 
The balances which are constituted of deferred taxes related to income tax loss carryforwards and negative basis of social contribution base are as follows:
 
   
12/31/2019
   
12/31/2018
 
Cia. Ultragaz
   12,808    37,332 
Oxiteno S.A.
   148,306    43,645 
Iconic
   17,657    28,256 
Extrafarma
   72,318    98,803 
Ultrapar
   24,632    —   
Ultrapar International
   2,419    —   
  
 
 
   
 
 
 
   278,140    208,036 
  
 
 
   
 
 
 
The technical study of the realization of deferred tax assets was approved by the Company’s CA, according Note 9.a.
The balances which are not constituted of deferred taxes related to income tax loss carryforwards and negative basis of social contribution base are as follows:
 
   
12/31/2019
   
12/31/2018
 
Extrafarma
   237,664    94,115 
Integra Frotas
   4,636    1,365 
Oxiteno Argentina
   0    22 
Oxiteno USA
   127,992    124,864 
Oxiteno Andina
   0    466 
  
 
 
   
 
 
 
  
 
370,292
 
  
 
220,832